Trogenix Unveils Revolutionary Platform to Transform Cancer Treatment Through Precision Viral ImmunotherapyCompany founded by 4BIO Capital and ...

Press Release4BIO Capital Portfolio Company Trogenix Unveils Revolutionary Platform to Transform Cancer Treatment Through Precision Viral ...

An experimental vaccine showed promise in treating aggressive breast cancer, while a new gene therapy method advances ...

In 1937, President Franklin Roosevelt signed the National Cancer Act, launching a nationwide effort to combat the disease.

NexCAR19 CAR-T treatment is being developed in India by IIT Bombay, Tata Memorial Centre, and industry partner immunoACT.

Researchers have combined two gene editing methods. This enables them to quickly investigate the significance of many genetic mutations involved in the development and treatment of cancer.

To improve long-term persistence and reduce the risk of immune rejection, researchers are exploring ways to diminish the ...

The U.S. Food and Drug Administration on Tuesday extended the review of Merus NV's gene-targeting cancer therapy to allow ...

A team created UAB36, a polygenic score based on 36 genes linked to drug resistance, showing promise in predicting cancer ...

Elevidys, a gene therapy from ... to develop StitchR treatments for other diseases caused by large genes. Nerve protection ...

The Mass General Brigham Gene and Cell Therapy Institute, a hub of innovation dedicated to accelerating groundbreaking research, conducting clinical trials and developing FDA-approved treatments, ...

Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced ...